New light on white matter

Stroke

Volumn 34, Issue 2, 2003, Pages 330-332

  Goldberg, Mark P ^a   Ransom, Bruce R ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Axons; Ischemia; Magnetic resonance imaging; Oligodendrocyte; White matter

Indexed keywords

BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RECEPTOR BLOCKING; SHORT SURVEY; WHITE MATTER;

ANIMALS; AXONS; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA;

EID: 0037319340     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000054048.22626.B9     Document Type: Short Survey

References (50)

1. Marcoux FW, Morawetz RB, Crowell RM, DeGirolami U, Halsey JH Jr. Differential regional vulnerability in transient focal cerebral ischemia. Stroke. 1982;13:339-346.
2. Zhang K, Sejnowski TJ. A universal scaling law between gray matter and white matter of cerebral cortex. Proc Natl Acad Sci USA. 2000;97: 5621-5626.
3. Nishizaki T, Yamauchi R, Tanimoto M, Okada Y. Effects of temperature on the oxygen consumption in thin slices from different brain regions. Neurosci Lett. 1988;86:301-305.
4. Pantoni L, Garcia JH, Gutierrez JA. Cerebral white matter is highly vulnerable to ischemia. Stroke. 1996;27:1641-1646; discussion 1647.
5. Filley CM. The Behavioral Neurology of White Matter. New York: Oxford University Press; 2001.
6. Pantoni L, Leys D, Fazekas F, Longstreth WT Jr, Inzitari D, Wallin A, Filippi M, Scheltens P, Erkinjuntti T, Hachinski V. Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord. 1999;13(suppl 3):S49-S54.
7. Desmond DW. Cognition and white matter lesions. Cerebrovasc Dis. 2002;13(suppl 2):53-57.
8. Stys PK, Waxman SG, Ransom BR. In: Axon T, Waxman S, Kocsis J, Stys P, eds. Ion Pumps and Exchangers. New York: Oxford University Press; 1995:296-310.
9. Waxman SG, Ransom BR, Stys PK. Non-synaptic mechanisms of Ca(2+)-mediated injury in CNS white matter. Trends Neurosci. 1991; 14:461-468.
10. Wender R, Brown AM, Fern R, Swanson RA, Farrell K, Ransom BR. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci. 2000;20:6804-6810.
11. Gallo V, Ghiani CA. Glutamate receptors in glia: new cells, new inputs and new functions. Trends Pharmacol Sci. 2000;21:252-258.
12. Yoshioka A, Hardy M, Younkin DP, Grinspan JB, Stem JL, Pleasure D. Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. J Neurochem. 1995;64:2442-2448.
13. Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc Natl Acad Sci USA. 1997;94:8830-8835.
14. McDonald JW, Althomsons SP, Hyrc KL, Choi DW, Goldberg MP. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med. 1998;4:291-297.
15. Fern R, Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci. 2000;20: 34-42.
16. Yoshioka A, Yamaya Y, Saiki S, Kanemoto M, Hirose G, Beesley J, Pleasure D. Non-N-methyl-D-aspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury. Brain Res. 2000;854:207-215.
17. Li S, Stys PK. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter. J Neurosci. 2000;20: 1190-1198.
18. Tekkok SB, Goldberg MP. AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. J Neurosci. 2001;21:4237-4248.
19. Kanellopoulos GK, Xu XM, Hsu CY, Lu X, Sundt TM, Kouchoukos NT. White matter injury in spinal cord ischemia: protection by AMPA/kainate glutamate receptor antagonism. Stroke. 2000;31:1945-1952.
20. McCracken E, Fowler JH, Dewar D, Morrison S, McCulloch J. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J Cereb Blood Flow Metab. 2002; 22:1090-1097.
21. Follett PL, Rosenberg PA, Volpe JJ, Jensen FE. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci. 2000;20: 9235-9241.
22. Wrathall JR, Choiniere D, Teng YD. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/ kainate antagonist NBQX. J Neurosci. 1994;14(11 Pt 1):6598-6607.
23. Pitt D, Werner P, Raine CS. Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med. 2000;6:67-70.
24. Smith T, Groom A, Zhu B, Turski L. Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat Med. 2000;6:62-66.
25. Matute C, Alberdi E, Domercq M, Perez-Cerda F, Perez-Samartin A, Sanchez-Gomez MV. The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 2001;24:224-230.
26. DeGraba TJ, Pettigrew LC. Why do neuroprotective drugs work in animals but not humans? Neurol Clin. 2000;18:475-493.
27. Lutsep H, Clark W. An update of neuroprotectants in clinical development for acute stroke. Curr Opin Investig Drugs. 2001;2:1732-1736.
28. Schabitz WR, Li F, Fisher M. The N-methyl-D-aspartate antagonist CNS 1102 protects cerebral gray and white matter from ischemic injury following temporary focal ischemia in rats. Stroke. 2000;31:1709-1714.
29. Yam PS, Dunn LT, Graham Dl, Dewar D, McCulloch J. NMDA receptor blockade fails to alter axonal injury in focal cerebral ischemia. J Cereb Blood Flow Metab. 2000;20:772-779.
30. Dewar D, Yam P, McCulloch J. Drug development for stroke: importance of protecting cerebral white matter. Eur J Pharmacol. 1999;375:41-50.
31. Akins PT, Atkinson RP. Glutamate AMPA receptor antagonist treatment for ischaemic stroke. Curr Med Res Opin. 2002;18(suppl 2):s9-s13.
32. Goldberg MP, ed. Stroke Trials Directory. Internet Stroke Center Web Site. www.strokecenter.org. Accessed December 12, 2002.
33. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG. Tyroler HA. Presence, and severity of cerebral white matter lesions and hypertension, its treatment, and its control: the ARIC Study Atherosclerosis Risk in Communities Study. Stroke. 1996;27:2262-2270.
34. Yamauchi H, Fukuda H, Oyanagi C. Significance of white matter high intensity lesions as a predictor of stroke from arteriolosclerosis. J Neurol Neurosurg Psychiatry. 2002;72:576-582.
35. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BE, Liao DP, Hubbard LD, Mosley TH. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA. 2002;288:67-74.
36. Neumann-Haefelin T, Moseley ME, Albers GW. New magnetic resonance imaging methods for cerebrovascular disease: emerging clinical applications. Ann Neurol. 2000;47:559-570.
37. Oliveira-Filho J, Ay H, Schaefer PW, Buonanno FS, Chang Y, Gonzalez RG, Koroshetz WJ. Diffusion-weighted magnetic resonance imaging identifies the "clinically relevant" small-penetrator infarcts. Arch Neurol. 2000;57:1009-1014.
38. Chalela JA, Wolf RL, Maldjian JA, Kasner SE. MRI identification of early white matter injury in anoxic-ischemic encephalopathy. Neurology. 2001;56:481-485.
39. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994;66:259-267.
40. Moseley ME, Cohen Y, Kucharczyk J, Mintorovitch J, Asgari HS, Wendland MF, Tsuruda J, Norman D. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology. 1990;176:439-445.
41. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology. 1996;201:637-648.
42. Shimony JS, McKinstry RC, Akbudak E, Aronovitz JA, Snyder AZ, Lori NF, Cull TS, Conturo TE. Quantitative diffusion-tensor anisotropy brain MR imaging: normative human data and anatomic analysis. Radiology. 1999;212:770-784.
43. Mukherjee P, Miller JH, Shimony JS, Conturo TE, Lee BC, Almli CR. McKinstry RC. Normal brain maturation during childhood: developmental trends characterized with diffusion-tensor MR imaging. Radiology. 2001;221:349-358.
44. Conturo TE, Lori NF, Cull TS, Akbudak E, Snyder AZ, Shimony JS, McKinstry RC, Burton H, Raichle ME. Tracking neuronal fiber pathways in the living human brain. Proc Natl Acad Sci USA. 1999;96: 10422-10427.
45. Mukherjee P, Bahn MM, McKinstry RC, Shimony JS, Cull TS, Akbudak-E, Snyder AZ, Conturo TE. Differences between gray matter and white matter water diffusion in stroke: diffusion-tensor MR imaging in 12 patients. Radiology. 2000;215:211-220.
46. Sorensen AG, Wu O, Copen WA, Davis TL, Gonzalez RG, Koroshetz WJ, Reese TG, Rosen BR, Wedeen VJ, Weisskoff RM. Human acute cerebral ischemia: detection of changes in water diffusion anisotropy by using MR imaging. Radiology. 1999;212:785-792.
47. Gillard JH, Papadakis NG, Martin K, Price CJ, Warburton EA, Antoun NM, Huang CL, Carpenter TA, Pickard JD. MR diffusion tensor imaging of white matter tract disruption in stroke at 3 T. Br J Radiol. 2001;74: 642-647.
48. Pendlebury ST, Blamire AM, Lee MA, Styles P, Matthews PM. Axonal injury in the internal capsule correlates with motor impairment after stroke. Stroke. 1999;30:956-962.
49. Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI. Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci U S A. 2002;99:9031-9036.
50. Papadopoulos CM, Tsai SY, Alsbiei T, O'Brien TE, Schwab ME, Kartje GL. Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol. 2002;51:433-441.